Close
Nordic 9Nordic 9

NYBC Ventures (investor - Corporate Investor)

United States nybc.org
See something wrong or missing? Let us know
Offices:Boston

NYBC Ventures is a $50 million invesment arm operated by the New York Blood Center in USA

Average round investment:31M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)
Portfolio companies: United Kingdom Cellular OriginsNetherlands Vitestro
Mostly invests in: United Kingdom United Kingdom (1) Manufacturing (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to NYBC Ventures

Name Criteria
Ireland Cantor Fitzgerald Private Clients
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Hong Kong CR-CP Life Science Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Kathaka
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Roquette Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States SAIC Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Rockspring
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mayo Clinic
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Rick Klausner
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan UTokyo IPC
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Charles River Laboratories
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top